SAGINAW, MI--(Marketwire - Feb 28, 2013) - HPIL Holding (OTCQB: HPIL) is pleased to announce that it has licensed its patents for the IFLOR Stimulating Massage Device to its wholly owned subsidiary, HPIL HEALTHCARE INC. The IFLOR device is a massaging vibrator for the relief of aches and pains (for more information, please see www.iflor.it). HPIL HEALTHCARE intends to develop, manufacture and market the IFLOR device worldwide.
Nitin Amersey, CFO of HPIL HOLDING said, "The IFLOR garnered the gold medal in the 32nd Salon for Inventions in Geneva, Switzerland, and we look forward to assisting HPIL Healthcare market it throughout the world, especially in countries where it is patented."
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding discussion, the words "pleased," "plan," "confident that," "believe," "expect," "intend to," "look forward to" and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the Company's products and technologies, competitive factors, the ability to successfully complete additional financings and other risks described in the Company's SEC reports and filings. Any forward-looking statement made press release is based only on information currently available to HPIL Holding and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.